Portfolio
Products
Pinaac Pharma Pvt Ltd based in Gurugram, Haryana, provides a specialized portfolio of pharmaceutical products focusing on oncology, nutraceuticals, and specialty medicines. Key products include Pitroze (tablet), Temoaac (tablet), Ironaac (tablet), Pirzole (tablet), and various anti-cancer medicines, such as Gefiaac (Gefitinib Tablets IP 250mg).
Nutraceuticals & nutritional wellness
Nutraceutical and wellness-oriented formulations alongside selected specialty tablet lines — for use under medical guidance.
Representative range
Lines and pack sizes vary by region. Share your requirement for the latest approved portfolio.
Contact us for product sheets and availability.
Oncology (anti-cancer) range
Anti-cancer and oncology-aligned tablet presentations, including Gefiaac and Temoaac, together with additional lines — subject to prescription and institutional protocols.
-
Gefiaac
Gefitinib Tablets IP 250mg — oncology use under specialist supervision and local registration.
-
Temoaac
Tablet presentation; used in oncology care pathways per approved indications.
-
Azaciaac
Tablet presentation; iron-focused formulation — strengths and pack sizes follow regional approvals.
-
Pitroze
Tablet presentation; part of our specialty medicines portfolio.
-
Pirzole
Tablet presentation; part of our specialty medicines portfolio.
Pain management
Illustrative lines in this segment are summarised below. Pack sizes, strengths, and registrations can vary by market—contact us for the latest approved portfolio in your region.
-
Azaciaac
Tablet presentation; iron-focused formulation — strengths and pack sizes follow regional approvals.
-
Pitroze
Tablet presentation; part of our specialty medicines portfolio.
-
Pirzole
Tablet presentation; part of our specialty medicines portfolio.
Important: Information on this page is for general awareness only and does not replace professional medical advice, diagnosis, or treatment. Always follow the guidance of your doctor or pharmacist.